Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Cholestatic Pruritus Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for cholestatic pruritus has markedly expanded over recent years. The market is projected to swell from $19.2 billion in 2024 to $20.22 billion in 2025, marking a compound annual growth rate (CAGR) of 5.3%. Factors such as the increasing incidence of skin disorders, a surge in research and development investments, the need for potent treatments, a rising disease awareness, along with accommodating regulatory climates, have all contributed to the growth evident in the previous period.
The market size for cholestatic pruritus is projected to witness considerable growth in the coming years, expected to reach a valuation of$24.78 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.2%. Several factors can be attributed to this growth in the forecast period including the increasing number of elderly individuals, rising instances of atopic dermatitis and urticaria, growth in the geriatric demographic, an surge in chronic kidney diseases, and the escalating cases of conditions related to pruritus. The forecast period is also anticipated to observe key trends such as the emergence of new therapeutic choices, collaborations with significant enterprises for cholestasis pruritus research, advancement in treatment methods, enlargement of healthcare infrastructures, and technological innovations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp
What are the Fundamental Drivers and Innovations Shaping the Cholestatic Pruritus Market?
The rise in liver disease cases is anticipated to spur the expansion of the cholestatic pruritus market. Liver illnesses encompass a wide spectrum of conditions that impair the functioning of the liver, including infections, autoimmune diseases, genetic disorders, and damage from toxins, which can result in inflammation, scarring, or liver failure. An upward trend in obesity, diabetes, alcohol consumption, viral hepatitis infections, and exposure to toxins and environmental influences is driving the heightened incidence of liver diseases. As a critical symptom indicating hindered bile flow, cholestatic pruritus aids in the detection and management of liver diseases, often triggering further exploration and treatment of associated hepatic disorders. For instance, the Office for Health Improvement and Disparities, a UK government agency that targets health inequality, reported a 22% increase in hospital admissions for liver disease in England in the year ending 2022, with numbers escalating from 67,458 to 82,290 as recorded in July 2023. Thus, the continued rise in liver disease cases is predicted to stimulate the expansion of the cholestatic pruritus market.
How Is the Cholestatic Pruritus Market Segmented?
The cholestatic pruritusmarket covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types
2) By Treatment Type: Medications; Phototherapy; Other Treatment Types
3) By Route Of Administration: Oral; Topical; Injectable
4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare
Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp
Which Regions Are Driving the Next Phase of the Cholestatic Pruritus Market Growth?
North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Cholestatic Pruritus Market?
Leading businesses in the cholestatic pruritus sector are concentrating on the development of novel solutions, such as oral treatments, to more successfully manage symptoms, enhance patient adherence, and offer targeted alleviation by tackling the root causes of bile salt buildup and inflammation. A liquid medication formulation designed to minimize bile acid buildup and soothe severe itching in patients with cholestasis is what constitutes an oral treatment for cholestatic pruritus. For instance, in March 2024, Mirum Pharmaceuticals Inc., a biopharmaceutical company based in the US, was granted authorization by the U.S. Food and Drug Administration (FDA) for their LIVMARLI (maralixibat) oral solution to treat cholestatic pruritus in patients who are five years and older and suffer from Progressive Familial Intrahepatic Cholestasis (PFIC). This orally taken ileal bile acid transporter inhibitor, administered once daily, has a breakthrough therapy designation for PFIC type 2. LIVMARLI is in a position to significantly affect patients with PFIC-related cholestatic pruritus, providing a much-desired treatment alternative for those with the rarest subtypes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report
How Is the Cholestatic Pruritus Market Defined and What Are Its Core Parameters?
Cholestatic pruritus refers to severe itching caused by the buildup of bile acids in the skin, typically resulting from liver diseases that impair bile flow. This condition can significantly affect a patient’s quality of life and often requires targeted treatment to manage the discomfort and address the underlying liver dysfunction.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21140
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model